Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response

  1. Philip G. Drennan
  2. Nicholas Provine
  3. Stephanie A. Harris
  4. Ashley Otter
  5. Jekaterina Hollett
  6. Cushla Cooper
  7. Roel PH De Maeyer
  8. Beatrice Nassanga
  9. Alberta Ateere
  10. Maria Fransiska Pudjohartono
  11. Yanchun Peng
  12. Ji-Li Chen
  13. Scott Jones
  14. Nurul Huda Mohamad Fadzillah
  15. Alba Grifoni
  16. Alessandro Sette
  17. Iman Satti
  18. Sam M. Murray
  19. Cathy Rowe
  20. Sema Mandal
  21. Bassam Hallis
  22. Paul Klenerman
  23. Tao Dong
  24. Duncan Richards
  25. James Fullerton
  26. Helen McShane
  27. Mark Coles

Reviewed by

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Rapid Reviews Infectious Diseases

    Malika Aid

    Review 1: "Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response"

    Overall, the study contributes valuable insights into mpox vaccine-induced immunity and offers a promising approach for identifying biomarkers of vaccine responsiveness. Future research should address durability of protection and generalizability across populations.

  3. Version published to 10.2139/ssrn.4955295